Biotech stocks remain under selling pressure. Sector component Amgen, Inc. (AMGN) still has some “meat on the bone” left to the downside. Please observe the chart below. Following its bounce from early November lows, AMGN has formed a descending triangle. Yesterday, the stock closed just under the bottom of the triangle which has very limited […]

This content is available only to members.
Register now for FREE access

Register   Log In

TD Ameritrade, Inc. and Shadow Trader Technologies LLC are separate, unaffiliated companies and are not responsible for each other’s services and products

Don’t Have a TD Ameritrade Account?

Do you put on a blindfold when you drive too? Open an account with TD Ameritrade today and get everything ShadowTrader has to offer including the live SquawkBox and more!

"Danno" Sheehy

View all author Posts